English

VOR BIOPHARMA INC.

EDGAR

VOR Quarterly report (10-Q) · filed 2026-10-30

35 filing records in this dataset, filed from 2021-01-15 to 2026-10-30. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Cash and cash equivalents: 79 million USD 2026-09-30 Source
Exact value

78977000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 61.4 million shares 2026-09-30 Source
Exact value

61429555 shares

Reported share-count change

580.51% · 52.4 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

9026922 shares · 2025-09-30· Source
61429555 shares · 2026-09-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

1.35 billion USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Net income: -695981000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -2418839000 USD · 2025-01-01 – 2025-09-30 Source
Net income: -219582000 USD · 2026-01-01 – 2026-03-31 Source
Net income: -62810000 USD · 2026-04-01 – 2026-06-30 Source
Net income: -86727000 USD · 2026-07-01 – 2026-09-30 Source

Operating cash flow

-119 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -142713000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -119912000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -38246000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -63624000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -38246000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -96370000 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: -63624000 USD · 2026-01-01 – 2026-06-30 Source

Capital expenditure

507 thousand USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Capital expenditure: 941000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 627000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 48000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 168000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 48000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 193000 USD · 2026-01-01 – 2026-09-30 Source
Capital expenditure: 168000 USD · 2026-01-01 – 2026-06-30 Source

Free cash flow

-120 million USD

2025-10-01 – 2026-09-30

Exact inputs and evidence

Operating cash flow: -142713000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -119912000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -38246000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -63624000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -38246000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -96370000 USD · 2026-01-01 – 2026-09-30 Source
Operating cash flow: -63624000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 941000 USD · 2025-01-01 – 2025-12-31 Source
Capital expenditure: 627000 USD · 2025-01-01 – 2025-09-30 Source
Capital expenditure: 48000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 168000 USD · 2026-01-01 – 2026-06-30 Source
Capital expenditure: 48000 USD · 2026-01-01 – 2026-03-31 Source
Capital expenditure: 193000 USD · 2026-01-01 – 2026-09-30 Source
Capital expenditure: 168000 USD · 2026-01-01 – 2026-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-30.

Financial data available through: 2025-12-31.

Coverage by financial measure

revenue: No compatible figures in this window
Operating income: 6 of 11 periods available· newest 2025-12-31
Net income: 6 of 11 periods available· newest 2025-12-31
Operating cash flow: 6 of 11 periods available· newest 2025-12-31
Capital expenditure: 6 of 11 periods available· newest 2025-12-31
Total assets: 6 of 11 periods available· newest 2025-12-31
Total liabilities: 6 of 11 periods available· newest 2025-12-31
Current assets: 6 of 11 periods available· newest 2025-12-31
Current liabilities: 6 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 6 of 11 periods available· newest 2025-12-31
long term debt: No compatible figures in this window
Shares outstanding: 6 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
−USD 579.07 million

Prior period

−USD 116.91 million

2024-01-01 – 2024-12-31
Current period

−USD 695.98 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-695981000 − -116914000 = -579067000 USD

-116914000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-695981000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Year-over-year change in Net income: -579067000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -695981000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#3378211 Filing: 000119312526130451 Input fundies:NetIncome: -116914000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#3380072 Filing: 000119312526130451
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 43.05 million

Prior period

−USD 99.66 million

2024-01-01 – 2024-12-31
Current period

−USD 142.71 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-142713000 − -99660000 = -43053000 USD

-99660000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-142713000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Year-over-year change in Operating cash flow: -43053000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -142713000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2313636 Filing: 000119312526130451 Input fundies:OperatingCashFlow: -99660000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2315517 Filing: 000119312526130451
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+310.9%

Prior period

USD 229,000

2024-01-01 – 2024-12-31
Current period

USD 941,000

2025-01-01 – 2025-12-31

Exact inputs and evidence

941000 − 229000 = 712000 USD

229000 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
941000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Year-over-year change in Capital expenditure: 712000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 941000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2328262 Filing: 000119312526130451 Input fundies:CapitalExpenditure: 229000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2330026 Filing: 000119312526130451
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.

Values and sources

Revenue values and source evidence
Period	Series	Value	Source evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.

Values and sources

Operating cash flow values and source evidence
Period	Series	Value	Source evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2020 2020-01-01 – 2020-12-31	−USD 43.34 million Exact value Exact value: -43337000 USD 2020-01-01 – 2020-12-31: -43337000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VOR BIOPHARMA INC. · 2020-12-31 VOR BIOPHARMA INC. (edgar:1817229) Net Income: -43337000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -43337000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017022003577/vor-20211231.htm#4075237 Filing: 000095017022003577 The citation records this snapshot. The page link may show a newer release later.	−USD 36.29 million Exact value Exact value: -36292000 USD 2020-01-01 – 2020-12-31: -36292000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VOR BIOPHARMA INC. · 2020-12-31 VOR BIOPHARMA INC. (edgar:1817229) Operating Cash Flow: -36292000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -36292000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017022003577/vor-20211231.htm#3136943 Filing: 000095017022003577 The citation records this snapshot. The page link may show a newer release later.	USD 4.16 million Exact value Exact value: 4161000 USD 2020-01-01 – 2020-12-31: 4161000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VOR BIOPHARMA INC. · 2020-12-31 VOR BIOPHARMA INC. (edgar:1817229) Capital Expenditure: 4161000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 4161000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017022003577/vor-20211231.htm#3148234 Filing: 000095017022003577 The citation records this snapshot. The page link may show a newer release later.	−USD 40.45 million Calculation and evidence -36292000 − 4161000 USD Exact free cash flow: -40453000 USD 2020-01-01 – 2020-12-31: -36292000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 4161000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VOR BIOPHARMA INC. · 2020-12-31 VOR BIOPHARMA INC. (edgar:1817229) Free cash flow: -40453000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -36292000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017022003577/vor-20211231.htm#3136943 Filing: 000095017022003577 Input fundies:CapitalExpenditure: 4161000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017022003577/vor-20211231.htm#3148234 Filing: 000095017022003577 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 68.9 million Exact value Exact value: -68899000 USD 2021-01-01 – 2021-12-31: -68899000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VOR BIOPHARMA INC. · 2021-12-31 VOR BIOPHARMA INC. (edgar:1817229) Net Income: -68899000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -68899000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017023009472/vor-20221231.htm#4050878 Filing: 000095017023009472 The citation records this snapshot. The page link may show a newer release later.	−USD 69.14 million Exact value Exact value: -69144000 USD 2021-01-01 – 2021-12-31: -69144000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VOR BIOPHARMA INC. · 2021-12-31 VOR BIOPHARMA INC. (edgar:1817229) Operating Cash Flow: -69144000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -69144000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017023009472/vor-20221231.htm#2924266 Filing: 000095017023009472 The citation records this snapshot. The page link may show a newer release later.	USD 3.89 million Exact value Exact value: 3894000 USD 2021-01-01 – 2021-12-31: 3894000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VOR BIOPHARMA INC. · 2021-12-31 VOR BIOPHARMA INC. (edgar:1817229) Capital Expenditure: 3894000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 3894000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017023009472/vor-20221231.htm#2941460 Filing: 000095017023009472 The citation records this snapshot. The page link may show a newer release later.	−USD 73.04 million Calculation and evidence -69144000 − 3894000 USD Exact free cash flow: -73038000 USD 2021-01-01 – 2021-12-31: -69144000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 3894000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VOR BIOPHARMA INC. · 2021-12-31 VOR BIOPHARMA INC. (edgar:1817229) Free cash flow: -73038000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -69144000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017023009472/vor-20221231.htm#2924266 Filing: 000095017023009472 Input fundies:CapitalExpenditure: 3894000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017023009472/vor-20221231.htm#2941460 Filing: 000095017023009472 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 92.09 million Exact value Exact value: -92094000 USD 2022-01-01 – 2022-12-31: -92094000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VOR BIOPHARMA INC. · 2022-12-31 VOR BIOPHARMA INC. (edgar:1817229) Net Income: -92094000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -92094000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017024034146/vor-20231231.htm#1795355 Filing: 000095017024034146 The citation records this snapshot. The page link may show a newer release later.	−USD 85.14 million Exact value Exact value: -85144000 USD 2022-01-01 – 2022-12-31: -85144000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VOR BIOPHARMA INC. · 2022-12-31 VOR BIOPHARMA INC. (edgar:1817229) Operating Cash Flow: -85144000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -85144000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017024034146/vor-20231231.htm#1889374 Filing: 000095017024034146 The citation records this snapshot. The page link may show a newer release later.	USD 8.46 million Exact value Exact value: 8462000 USD 2022-01-01 – 2022-12-31: 8462000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VOR BIOPHARMA INC. · 2022-12-31 VOR BIOPHARMA INC. (edgar:1817229) Capital Expenditure: 8462000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 8462000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017024034146/vor-20231231.htm#1900360 Filing: 000095017024034146 The citation records this snapshot. The page link may show a newer release later.	−USD 93.61 million Calculation and evidence -85144000 − 8462000 USD Exact free cash flow: -93606000 USD 2022-01-01 – 2022-12-31: -85144000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 8462000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VOR BIOPHARMA INC. · 2022-12-31 VOR BIOPHARMA INC. (edgar:1817229) Free cash flow: -93606000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -85144000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017024034146/vor-20231231.htm#1889374 Filing: 000095017024034146 Input fundies:CapitalExpenditure: 8462000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017024034146/vor-20231231.htm#1900360 Filing: 000095017024034146 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 117.86 million Exact value Exact value: -117863000 USD 2023-01-01 – 2023-12-31: -117863000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VOR BIOPHARMA INC. · 2023-12-31 VOR BIOPHARMA INC. (edgar:1817229) Net Income: -117863000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -117863000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017025042623/vor-20241231.htm#3155499 Filing: 000095017025042623 The citation records this snapshot. The page link may show a newer release later.	−USD 100.29 million Exact value Exact value: -100292000 USD 2023-01-01 – 2023-12-31: -100292000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VOR BIOPHARMA INC. · 2023-12-31 VOR BIOPHARMA INC. (edgar:1817229) Operating Cash Flow: -100292000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -100292000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017025042623/vor-20241231.htm#2201570 Filing: 000095017025042623 The citation records this snapshot. The page link may show a newer release later.	USD 1.07 million Exact value Exact value: 1069000 USD 2023-01-01 – 2023-12-31: 1069000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VOR BIOPHARMA INC. · 2023-12-31 VOR BIOPHARMA INC. (edgar:1817229) Capital Expenditure: 1069000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1069000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017025042623/vor-20241231.htm#2215244 Filing: 000095017025042623 The citation records this snapshot. The page link may show a newer release later.	−USD 101.36 million Calculation and evidence -100292000 − 1069000 USD Exact free cash flow: -101361000 USD 2023-01-01 – 2023-12-31: -100292000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 1069000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VOR BIOPHARMA INC. · 2023-12-31 VOR BIOPHARMA INC. (edgar:1817229) Free cash flow: -101361000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -100292000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017025042623/vor-20241231.htm#2201570 Filing: 000095017025042623 Input fundies:CapitalExpenditure: 1069000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000095017025042623/vor-20241231.htm#2215244 Filing: 000095017025042623 The citation records this snapshot. The page link may show a newer release later.
2024 2024-01-01 – 2024-12-31	−USD 116.91 million Exact value Exact value: -116914000 USD 2024-01-01 – 2024-12-31: -116914000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VOR BIOPHARMA INC. · 2024-12-31 VOR BIOPHARMA INC. (edgar:1817229) Net Income: -116914000 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -116914000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#3380072 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.	−USD 99.66 million Exact value Exact value: -99660000 USD 2024-01-01 – 2024-12-31: -99660000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VOR BIOPHARMA INC. · 2024-12-31 VOR BIOPHARMA INC. (edgar:1817229) Operating Cash Flow: -99660000 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -99660000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2315517 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.	USD 229,000 Exact value Exact value: 229000 USD 2024-01-01 – 2024-12-31: 229000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VOR BIOPHARMA INC. · 2024-12-31 VOR BIOPHARMA INC. (edgar:1817229) Capital Expenditure: 229000 USD Concept: fundies:CapitalExpenditure Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ACapitalExpenditure&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 229000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2330026 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.	−USD 99.89 million Calculation and evidence -99660000 − 229000 USD Exact free cash flow: -99889000 USD 2024-01-01 – 2024-12-31: -99660000 USD · Inspect Operating Cash Flow · Source 2024-01-01 – 2024-12-31: 229000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VOR BIOPHARMA INC. · 2024-12-31 VOR BIOPHARMA INC. (edgar:1817229) Free cash flow: -99889000 USD Concept: free-cash-flow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -99660000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2315517 Filing: 000119312526130451 Input fundies:CapitalExpenditure: 229000 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2330026 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.
2025 2025-01-01 – 2025-12-31	−USD 695.98 million Exact value Exact value: -695981000 USD 2025-01-01 – 2025-12-31: -695981000 USD Inspect Net Income Open source Share or cite Citation for Net Income · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Net Income: -695981000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: -695981000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#3378211 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.	−USD 142.71 million Exact value Exact value: -142713000 USD 2025-01-01 – 2025-12-31: -142713000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Operating Cash Flow: -142713000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -142713000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2313636 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.	USD 941,000 Exact value Exact value: 941000 USD 2025-01-01 – 2025-12-31: 941000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Capital Expenditure: 941000 USD Concept: fundies:CapitalExpenditure Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229/explain?concept=fundies%3ACapitalExpenditure&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 941000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2328262 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.	−USD 143.65 million Calculation and evidence -142713000 − 941000 USD Exact free cash flow: -143654000 USD 2025-01-01 – 2025-12-31: -142713000 USD · Inspect Operating Cash Flow · Source 2025-01-01 – 2025-12-31: 941000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · VOR BIOPHARMA INC. · 2025-12-31 VOR BIOPHARMA INC. (edgar:1817229) Free cash flow: -143654000 USD Concept: free-cash-flow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T09:32:59Z Snapshot: 2e167c544acd282b1ed83fd55a50ba564bc60fa7bc814e8250bdebe50baf9663 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1817229?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -142713000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2313636 Filing: 000119312526130451 Input fundies:CapitalExpenditure: 941000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1817229/000119312526130451/vor-20251231.htm#2328262 Filing: 000119312526130451 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

35 filings · 1,406 latest values · 1,406 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001817229, 1817229, VOR, edgar:1817229

Also known as VOR BIOPHARMA INC., Vor Biopharma Inc.

VOR BIOPHARMA INC.

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Capital expenditure

Where revenue goes

Growth

Profit and cash

Balance sheet

Cash generation